Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.7
3.0
Journals
JCM
Announcements
jcm-logo

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Announcements

10 January 2025
Journal of Clinical Medicine | 2024 Editorial Board Meeting of the Section “Obstetrics and Gynecology”


Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held its Editorial Board meeting for the Section “Obstetrics and Gynecology”, which was hosted by the Section Editor-in-Chief, Prof. Dr. Eyal Sheiner. Thirteen Editorial Board Members were in attendance on 17 December 2024. We are extremely grateful for the strong support of our Editorial Board Members and for the opportunity to have a face-to-face meeting to discuss the development of the Section, and we sincerely hope that more Editorial Board Members can join future meetings. We would like to invite you to review the contents of the Editorial Board meeting.

We discussed the following topics with the members:

  • The journal’s history, open access policy, and author benefits;
  • Journal publication statistics and an analysis of author distribution (2018–2024);
  • Journal awards, marketing activities, and social media promotion;
  • Section EBM overview, decision-making statistics, and Section development statistics.

The following information was covered in the Members’ discussion: We clearly defined our goal to provide high-quality publishing services, control peer review, publish high-quality articles, and provide a communication platform for health professionals. A series of practical measures were put forward for the Section to achieve this objective. First, we insist on having a high-quality peer review process; submissions need to be checked carefully. Meta-analysis reviews and interventional studies are welcomed. Secondly, we need to create a variety of Special Issues and actively promote highly cited Special Issues, which will draw more attention. Furthermore, we encourage the invitation of more influential scholars, especially obstetricians and gynecologists with statistical backgrounds to join the Section. Members also recommended some related congresses and associations to us for future collaborations. We believe that by implementing these measures, we can inject new vitality into the development of the Section and help the journal to move to a higher level.

Attendee list (in no particular order):

  • Prof. Dr. Eyal Sheiner (Section Editor-in-Chief)—Department of Obstetrics and Gynecology, Soroka University Medical Center, Israel;
  • Prof. Dr. Alberto Revelli—Obstetrics and Gynecology SCDU1, Reproductive Medicine and IVF Unit, Department of Surgical Sciences, University of Torino, Sant'Anna Hospital, Italy;
  • Prof. Dr. Jacek Malejczyk—Department of Histology and Embryology, Medical University of Warsaw, Poland;
  • Dr. Johannes Ott—Clinical Division of Gynecologic Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Austria;
  • Prof. Dr. Philippe R. Koninckx—1 Latifa Hospital, United Arab Emirates; 2 Department of OBGYN, Faculty of Medicine, Katholieke University Leuven, Belgium; 3 Department of OBGYN, Faculty of Medicine, University of Oxford, UK; 4 Department of OBGYN, Faculty of Medicine, University of Cattolica, Italy; 5 Department of OBGYN, Faculty of Medicine, Moscow State University, Russia;
  • Prof. Dr. Błażej Męczekalski—Department of Gynaecological Endocrinology, Poznan University of Medical Sciences, Poland;
  • Dr. Kanna Jayaprakasan—Derby Fertility Unit, Royal Derby Hospital, UK;
  • Dr. Hananel E. G. Holzer—1 The Fertility Partners, Canada; 2 Department of Obstetrics and Gynecology, McGill University Montreal, Canada;
  • Prof. Dr. Vito Cela—Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Italy;
  • Prof. Dr. Sorina Grisaru-Granovsky—Department of Obstetrics & Gynecology, Shaare Zedek Medical Center, Hadassah School of Medicine, Hebrew University of Jerusalem, Israel;
  • Dr. Federico Prefumo—Department of Obstetrics & Gynecology, Shaare Zedek Medical Center, Hadassah School of Medicine, Hebrew University of Jerusalem, Israel;
  • Prof. Dr. Ariel Many—Department of Obstetrics and Gynecology, Mayanei Hayeshua Medical Center, Israel;
  • Dr. Elvira Grandone—1 Department of Obstetrics and Gynecology, University of Foggia, Italy; 2 Thrombosis and Haemostasis Unit, Fondazione IRCCS “Casa Sollievo della Sofferenza”, Italy;
  • Prof. Dr. Simone Ferrero—IRCCS Ospedale Policlinico San Martino, University of Genova, Italy.

The latest official CiteScore (2023 Scopus data) for the Journal of Clinical Medicine is 5.7, ranking 80/636 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.0 (2023), ranking 59/329 (Q1) in the “Medicine, General, and Internal” category. To access more journal statistics, please click here.

To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Obstetrics_Gynecology.

JCM Editorial Office

9 January 2025
JCM Webinar | Glomerular Diseases Pathophysiology and Treatment, 20 January 2025


This webinar will review the state of the art in the pathophysiology and management of three important glomerular diseases: IgA nephropathy, the most frequent primary glomerular disease worldwide; membranous nephropathy, the paradigm of autoimmune glomerular diseases; and lupus nephritis, the most severe complication of systemic lupus erythematosus.

Each of these diseases will be discussed by an eminent expert in the field, namely Prof. Rosanna Coppo for IgA nephropathy, Prof. Lucia Del Vecchio for membranous nephropathy, and Prof. Gabriella Moroni for lupus nephritis. In their comprehensive yet concise presentations, the speakers will provide not only an evidence-based review of the topic but also practical recommendations to guide the day-to-day management of individual patients. Every talk will be followed by questions from the audience and answers from the speakers. The discussion will be managed by the chairs.

The main goal of this webinar is to provide practical information organized in an understandable manner. We are confident that our invited experts will be able to achieve this goal.

Date: 20 January 2025
Time: 4:00 p.m. CET | 10:00 a.m. EST | 11:00 p.m. CST Asia 
Webinar ID: 831 9896 4221
Webinar Secretariat: journal.webinar@mdpi.com
Webinar announcement: https://sciforum.net/event/JCM-13

Register now for free!

Speaker/Presentation

Time in CEST/CET (Basel time)

Time in EST

Prof. Dr. Francesco Locatelli and Prof Dr. Claudio Ponticelli
Chair Introduction

4:00–4:10 p.m.

10:00–10:10 a.m.

Prof. Rosanna Coppo
Treating IgA nephropathy: looking at the future without forgetting the past

4:10–4:30 p.m.

10:10–10:30 a.m.

Prof. Lucia Del Vecchio
The treatment of membranous nephropathy in the era of precision medicine

4:30–4:50 p.m.

10:30–10:50 a.m.

Prof. Gabriella Moroni
New frontiers in lupus nephritis

4:50–5:10 p.m.

10:50–11:10 a.m.

Q&A Session

5:10–5:25 p.m.

11:10–11:25 a.m.

Prof. Dr. Francesco Locatelli and Prof. Dr. Claudio Ponticelli
Closing of Webinar

5:25–5:30 p.m.

11:25–11:30 a.m.

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic or institutional email addresses will be prioritized.

Unable to attend? Feel free to still register; we will inform you when the recording is available.

Webinar Chair and Keynote Speakers:

  • Prof. Dr. Francesco Locatelli, Department of Nephrology and Dialysis, Alessando Manzoni Hospital, Lecco, Italy;
  • Prof. Dr. Claudio Ponticelli, Director Nephrology Division, Ospedale Maggiore, Milan, Italy;
  • Prof. Rosanna Coppo, Freelance nephrologist. Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy;
  • Prof. Lucia Del Vecchio, Department of Nephrology and Dialysis, ASST Lariana, Como, Italy;
  • Prof. Gabriella Moroni, 1Department of Biomedical Sciences, Humanitas University, Milan, Italy; 2Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Milan, Italy.

Relevant Special Issue:
“Novelties in the Treatment of Glomerulonephritis”
Guest Editor: Prof. Dr. Francesco Locatelli
Deadline for manuscript submissions: 30 April 2025

7 January 2025
MDPI INSIGHTS: The CEO's Letter #19 - Reflecting on 2024, Society Journals, OA Germany

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflecting on 2024: Celebrating Our Progress and People

As we reflect on the year gone by, I’m proud and thankful for what we’ve accomplished together. This has been a year of growth, learning, and resilience, all of which have shaped MDPI’s journey. I would like to thank each of our employees for their dedication, hard work, and commitment to advancing open access (OA) publishing.

Our growth is evident: from about 5,900 colleagues at the end of 2023 to over 6,650 today, our global MDPI community continues to expand. We expanded our global operations with a new office in Seoul, South Korea, and celebrated a record-breaking year with 60 MDPI journals newly indexed in the Web of Science and 37 MDPI journals accepted into Scopus. As at 30 December, 2024, we publish 457 journals, of which 448 are peer-reviewed and 9 dedicated to academic conference outputs. Of these, 306 are indexed in Scopus, 298 in the Web of Science, and 90 in PubMed.

Looking for a new role in 2025? We have a variety of roles currently open!

Yet, growth never comes without its challenges. This year, we faced setbacks, including the removal of the Journal of Personalized Medicine from the Web of Science due to content relevance concerns. Our editorial and research integrity teams are actively addressing these issues, and we aim to reapply for indexation in December 2026. On another front, the decision by JUFO, The Finnish Publication Forum, to downgrade many MDPI journals presented a challenge. However, we are engaging with the Finnish research community and our editorial boards to provide scientific data supporting a reevaluation of MDPI journals in alignment with Finland’s national open access policies.

These examples remind us that challenges are part of our journey. What defines us is how we respond, by learning, adapting, and improving our practices and operations.

On the partnerships front, we achieved a landmark national open access agreement with over 100 German universities, effective 1 January 2025, bringing our total of Institutional Open Access Program (IOAP) partners to over 950. These achievements reflect not just our ambition but also the trust placed in MDPI by our collaborators worldwide.

Amidst growth and change, one constant remains: the people of MDPI. This year, I had the privilege of representing MDPI at important meetings and conferences from Beijing to Krakow, while visiting many of our offices, from Tokyo and Cluj to Manchester and Toronto. The highlight of my year has been meeting and connecting with so many of you.

“MDPI thrives because of community and collaboration”

When asked what makes MDPI a great place to work, my answer is simple: It’s the people. Our authors frequently praise the support and professionalism of our editorial staff. That same care extends inward, reflected in the friendships and collaborations we regularly nurture with our colleagues. MDPI thrives because of the community and collaboration that drives us forward.

As the African proverb states, “If you want to go fast, go alone. If you want to go far, go together.” I believe MDPI embodies both, being speedy in our daily operations and united in our purpose of promoting open access publishing.

Looking ahead to 2025, let us continue building a culture of care and support for one another, take pride in our work, and strive to improve all that we do. Thank you for making 2024 a special year, and I look forward to what we can achieve together in 2025.

PS: I look forward to sharing more about our people and the achievements of the past year in the 2024 Annual Report.

Impactful Research

685 MDPI Editors Named Highly Cited Researchers in 2024

I’m excited to celebrate the achievements of 685 Editorial Board Members (EBMs) from our journals, representing 39 countries and territories, who have been named Highly Cited Researchers for 2024 by Clarivate. This prestigious recognition highlights their scientific contributions, which transcend academic boundaries to drive progress in global knowledge, sustainability, security, and well-being.

Here, you’ll find the list of MDPI’s EBMs who have been recognized this year.

Clarivate’s annual Highly Cited Researcher™ list identifies the most influential scientists of the past decade – those whose work has made a profound and far-reaching impact across numerous scientific and social science disciplines. To be included on this list is no small feat. These researchers’ impactful papers rank among the top 1% by citations in one or more of the 21 fields analyzed within the “Essential Science Indicators,” positioning them as leaders in their domains.

As Clarivate notes, “Highly Cited Researchers have demonstrated significant and broad influence in their field(s) of research.” In 2024, a total of 6,886 Highly Cited Researcher designations were awarded to 6,636 individuals globally.

I extend my congratulations to all of MDPI’s EBMs who have achieved this milestone. Their dedication and excellence inspire us all and exemplify the high standards we uphold as a publisher. Congratulations to each of them for this incredible accomplishment and for their ongoing contributions to advancing knowledge in their fields.

Inside MDPI

How MDPI / Open Access Supports Societies

MDPI actively supports societies through the launch of new journals, the acquisition of established journals, and the transfer of society journals from other publishers. You can submit your proposal here.

Over the past 13 years, we have collaborated with over 190 learned societies and organizations. These partnerships range from affiliations with one or more of our journals to publishing journals on behalf of our partners.

Learn about how MDPI / Open Access Supports Societies.

In this section I highlight our Societies team, whose responsibilities include establishing new OA journals on behalf of societies and institutions, publishing an existing OA journal with MDPI or transitioning a subscription journal to an OA model, and establishing affiliations between societies and MDPI journals.

If you would like to learn more about these services, please see the Societies website.

The Societies team is led by Dr. Carla Aloè, Head of Societies and Acquisition, and her Deputy Manager, Dr. Clàudia Aunós. MDPI collaborates with a wide range of societies through various partnerships. For a complete list of collaborating societies and society journals, please visit the Societies website.

How long have you been at MDPI, and what was your first role?

I joined MDPI in September 2020 as an Associate Publisher and Scientific Officer, overseeing the Arts, Humanities, and Social Science journals. In July 2022, I took on the oversight of the Society and Acquisition team. 

Do you think that perceptions of Open Access are generally accurate?

Far from it: there are in fact many misconceptions surrounding the way Open Access works and the benefits it has to offer. A common misconception is that OA journals are poor quality, which is entirely untrue. Many of our journals are included in major indexing databases, and all of them are endorsed by prominent associations and committees such as the Committee on Publication Ethics (COPE), the International Association of Scientific, Technical, and Medical Publishers (STM), and the Open Access Scholarly Publication Association (OASPA). We uphold a rigorous peer-review process, adhere to strict ethical standards, and rely on high-profile editorial boards. 

How long have you been at MDPI, and what was your first role?

I’ve been at MDPI for almost seven years now. I started as an Assistant Editor but was quickly promoted to work with societies.

What is the most common question you get asked about the services that the Societies team provides?

For societies with a standard number of members (less than 500), the most common inquiry is about how much the publishing services we offer cost. One of the great things about our publishing services is that they are free of any burden cost to the society, regardless of the type of non-profit organization.  

For bigger non-profit organizations, it is more about what benefits they can get for their members and ensuring that their journals are in good hands.

Either way, the goal is the same: to listen to the demands of the market, be flexible, and help our partners achieve healthy and positive development of their journals.

Read more:

Coming Together for Science

2024 MDPI Conference Summary

Throughout 2024, the MDPI Conference Team connected with scientific communities by organizing nine in-person events and 26 virtual conferences. In order to support the need for our growing events, we expanded this team to a total of 37 people across all offices, including 18 members in Asia-Pacific and 20 in the EU and North America.

The nine large-scale in-person conferences organized brought together leading minds across diverse disciplines, including our conferences on Viruses, Molecules, Polymers, Materials, Non-Coding RNA, Pharmaceuticals, and Sensors. These events strengthened synergies with the scientific community, actively promoting our journals and the latest research published within their respective fields. These achievements highlight our Conference Team’s dedication to creating meaningful and memorable events in the academic field.

2024 Event Highlights

Viruses 2024, the 5th edition of the conference series, hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes. The event attracted 240 attendees from around the globe. With 47 talks and nearly 130 poster presentations, the conference explored the latest developments in viral pathogenesis and immune responses across six engaging sessions.

Molecules 2024, the fourth edition of this conference series, highlighted the impact of emerging drug modalities on drug discovery. The event brought together over 100 attendees from 22 countries and featured more than 80 submissions organized into six sessions. The program included talks by 12 invited speakers from Europe, Asia and the United States. An impressive 97% of attendees rated the conference as ‘Excellent’ or ‘Good.’

Polymers 2024, attracted over 300 attendees from 22 countries and featured 259 accepted abstracts. Focusing on green polymer chemistry and the use of bioresources, the conference highlighted advancements in the synthesis of biobased and biodegradable polymers. Engaging lectures by three keynote speakers and 12 invited speakers, coupled with dynamic discussions, led 94% of attendees to rate the conference as ‘Excellent’ or ‘Good.’

A high-profile summit in Toronto was organized by the team, which expanded our global reach and showcased our capacity to deliver impactful events in our different offices. Sixteen EiC and seven EBMs joined our event, and with a 100% rate of Excellent/Good, over 90% of them said they are likely to attend our next edition.

The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science successfully gathered about 400 participants onsite. Three hundred and fifty-five abstracts were accepted, with 772 authors from 28 countries. Across the four-day program, there were 296 talks delivered and 66 posters displayed.

The 2nd Sustainable Publishing Forum was successfully held in Beijing, China, with around 120 attendees from local publishers, editorial staff from local university presses, librarians, etc. The event is focused on promoting open science, maintaining research integrity and fulfilling social responsibility.

ICM 2024, the 5th International Conference on Materials, brought together scientists, researchers and industry leaders to explore advancements in materials characterization, processing and manufacturing. Topics ranged from nanotechnology and biomaterials to energy materials and AI-driven research. With 62 attendees from 26 different countries, the program featured 34 talks and 18 posters, fostering collaboration and innovation over 2.5 days.

The second edition of ncRNA 2024 welcomed 104 attendees from 30 countries, 71% of them being women. Two keynote speakers, Prof. Ling-Ling Chen and Prof. Mauro Giacca, shared insights drawn from over 10 years of experience. Prof. Giacca's groundbreaking work promises advances in curative therapies for heart failure, while Prof. Chen’s team continues to lead the development of the ncRNA field. High participant engagement generated valuable topics for future editions, and 96% of attendees rated the conference as ‘Excellent’ or ‘Good’.

Pharmaceuticals 2024, with its eight sessions, covered the newest technologies and the research areas of medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, among others. The conference featured three plenary and eight invited speakers, comprising esteemed scholars from eight different countries of Europe, and welcomed 64 participants from 28 different countries. Ninety-one percent of the attendees rated the conference as ‘Excellent’ or ‘Good’, highlighting the outstanding organzation of the event.

In 2024, we organized 26 virtual events with an average submission number of 158 abstracts per event, and an average registration number of 491 per event. Compared with the last edition, we saw a 42.2% growth of accepted abstract submissions.

The year 2024 marked a change in the strategy of our conference team, prioritizing the improvement of the communication and collaboration within our European and Asia-Pacific teams and creating stronger teamwork to elevate the quality and impact of MDPI events.

Scheduled Events in 2025

Closing Thoughts

Over 100 German Universities Partner with MDPI in New National Agreement  

I am pleased to share some exciting end-of-year news: MDPI has reached a major milestone by signing a publishing agreement with over 100 German universities and research institutions! Negotiated by ZB MED - Informationszentrum Lebenswissenschaften, the agreement came into effect on 1 January 2025 and will run until the end of 2026.

This new cooperation aims to make scientific Gold Open Access publishing more affordable and less administratively burdensome for researchers in Germany.

Learn more, here.

“Thank you to everyone who contributed to making this agreement a reality.”

Why is this important?

Germany is a global leader in academic research and publishing, ranking fifth in total MDPI publication volume.

This agreement reflects our growing influence and leadership in open access publishing.

Partnering with more than 100 institutions highlights MDPI’s reputation as a trusted publishing partner for the academic community.

As Peter Roth, MDPI Head of Publishing, noted:

“MDPI can look back on over a decade of successful partnerships with German research institutions. This agreement marks another milestone in our collaboration with the German scientific community.” 

Adrian Stefan Zamfir, Institutional Partnership Manager for the DACH region, added:

“We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform” 

Thank you to everyone who contributed to making this agreement a reality. This milestone reinforces MDPI as a trusted leader in advancing open access and supporting researchers worldwide.

Stefan Tochev
Chief Executive Officer
MDPI AG

7 January 2025
Journal of Clinical Medicine | Notable Papers in Q4 of 2024


The Journal of Clinical Medicine (JCM, ISSN: 2077-0383), as an open access journal, has always been committed to bringing together cutting-edge research results in the field of global clinical medicine and building a knowledge-sharing bridge for the majority of medical researchers. We are proud to present you with a selection of Altmetric high-scoring papers published in the Journal of Clinical Medicine for the fourth quarter of 2024.

The selected papers cover cutting-edge research in many areas of clinical medicine and stand out in terms of academic dissemination and social impact through their excellent Altmetric scores. Behind each paper is the wisdom and hard work of a team of outstanding scholars, and we would like to express our great respect and sincere gratitude to these outstanding researchers. These papers will be invaluable treasures of knowledge and sources of inspiration for scholars in related fields, and we encourage you to read these highly popular works in depth. Please click the links below to learn more about these papers.

1. “Iris Reconstruction: A Surgeon’s Guide”
by Lorenzo Ferro Desideri, Kirupakaran Arun, Grace Doherty, Enrico Bernardi and Rodrigo Anguita
J. Clin. Med. 2024, 13(9), 2706; https://doi.org/10.3390/jcm13092706
Full text available online: https://www.mdpi.com/2077-0383/13/9/2706

2. “Preclinical Evaluation of Electronic Health Records (EHRs) to Predict Poor Control of Chronic Respiratory Diseases in Primary Care: A Novel Approach to Focus Our Efforts”
by Fernando M. Navarro Ros and José David Maya Viejo
J. Clin. Med. 2024, 13(18), 5606; https://doi.org/10.3390/jcm13185609
Full text available online: https://www.mdpi.com/2077-0383/13/18/5609

3. “Bronchoscopic Diagnosis of Severe Respiratory Infections”
by Maire Röder, Anthony Yong Kheng Cordero Ng and Andrew Conway Morris
J. Clin. Med. 2024, 13(19), 6020; https://doi.org/10.3390/jcm13196020
Full text available online: https://www.mdpi.com/2077-0383/13/19/6020

4. “Rapid and Robust Identification of Sepsis Using SeptiCyte RAPID in a Heterogeneous Patient Population”
by Robert Balk, Annette M. Esper, Greg S. Martin, Russell R. Miller III, Bert K. Lopansri, John P. Burke, Mitchell Levy, Richard E. Rothman, Franco R. D’Alessio, Venkataramana K. Sidhaye et al.
J. Clin. Med. 2024, 13(20), 6044; https://doi.org/10.3390/jcm13206044
Full text available online: https://www.mdpi.com/2077-0383/13/20/6044

5. “Prevalence of Overweight and Obesity in France: The 2020 Obepi-Roche Study by the ’Ligue Contre l’Obésité’”
by Annick Fontbonne, Andrew Currie, Patrick Tounian, Marie-Christine Picot, Olivier Foulatier, Marius Nedelcu and David Nocca
J. Clin. Med. 2023, 12(3), 925; https://doi.org/10.3390/jcm12030925
Full text available online: https://www.mdpi.com/2077-0383/12/3/925

6. “Cannabis Use Variations and Myocardial Infarction: A Systematic Review”
by Jan van Amsterdam and Wim van den Brink
J. Clin. Med. 2024, 13(18), 5620; https://doi.org/10.3390/jcm13185620
Full text available online: https://www.mdpi.com/2077-0383/13/18/5620

7. “Clinical Recommendations for Managing Genitourinary Adverse Effects in Patients Treated with SGLT-2 Inhibitors: A Multidisciplinary Expert Consensus”
by Juan J. Gorgojo-Martínez, José L. Górriz, Ana Cebrián-Cuenca, Almudena Castro Conde and María Velasco Arribas
J. Clin. Med. 2024, 13(21), 6509; https://doi.org/10.3390/jcm13216509
Full text available online: https://www.mdpi.com/2077-0383/13/21/6509

8. “Diagnostic Image Quality of a Low-Field (0.55T) Knee MRI Protocol Using Deep Learning Image Reconstruction Compared with a Standard (1.5T) Knee MRI Protocol”
by Ingo Lopez Schmidt, Nina Haag, Iram Shahzadi, Lynn Johann Frohwein, Claus Schneider, Julius Henning Niehoff, Jan Robert Kroeger, Jan Borggrefe and Christoph Moenninghoff
J. Clin. Med. 2023, 12(5), 1916; https://doi.org/10.3390/jcm12051916
Full text available online: https://www.mdpi.com/2077-0383/12/3/1169

9. “A Meta-Analysis of the Global Prevalence of Temporomandibular Disorders”
by Grzegorz Zieliński, Beata Pająk-Zielińska and Michał Ginszt
J. Clin. Med. 2024, 13(5), 1365; https://doi.org/10.3390/jcm13051365
Full text available online: https://www.mdpi.com/2077-0383/13/5/1365

10. “Global Prevalence of Sleep Bruxism and Awake Bruxism in Pediatric and Adult Populations: A Systematic Review and Meta-Analysis”
by Grzegorz Zieliński, Agnieszka Pająk and Marcin Wójcicki
J. Clin. Med. 2024, 13(14), 4259; https://doi.org/10.3390/jcm13144259
Full text available online: https://www.mdpi.com/2077-0383/13/14/4259

11. “Sexual and Reproductive Outcomes in Obese Fertile Men with Functional Hypogonadism after Treatment with Liraglutide: Preliminary Results”
by Sandro La Vignera, Rosita A. Condorelli, Aldo E. Calogero, Rossella Cannarella and Antonio Aversa
J. Clin. Med. 2023, 12(2), 672; https://doi.org/10.3390/jcm12020672
Full text available online: https://www.mdpi.com/2077-0383/12/2/672

12. “Emergencies in Hematology: Why, When and How I Treat?”
by Andrea Duminuco, Vittorio Del Fabro, Paola De Luca, Dario Leotta, Miriana Carmela Limoli, Ermelinda Longo, Antonella Nardo, Gabriella Santuccio, Alessandro Petronaci, Gaia Stanzione et al.
J. Clin. Med. 2024, 13(24), 7572; https://doi.org/10.3390/jcm13247572
Full text available online: https://www.mdpi.com/2077-0383/13/24/7572

13. “Lipedema: Complications in High-Volume Liposuction Are Linked to Preoperative Anemia”
by Tonatiuh Flores, Barbara Kremsner, Jana Schön, Julia Riedl, Hugo Sabitzer, Christina Glisic, Kristina Pfoser, Jakob Nedomansky, Konstantin D. Bergmeister and Klaus F. Schrögendorfer
J. Clin. Med. 2024, 13(24), 7779; https://doi.org/10.3390/jcm13247779
Full text available online: https://www.mdpi.com/2077-0383/13/24/7779

14. “The Management of Interstitial Lung Disease in the ICU: A Comprehensive Review”
by Zehra Dhanani and Rohit Gupta
J. Clin. Med. 2024, 13(22), 6657; https://doi.org/10.3390/jcm13226657
Full text available online: https://www.mdpi.com/2077-0383/13/22/6657

15. “Critical Care Ultrasound in Shock: A Comprehensive Review of Ultrasound Protocol for Hemodynamic Assessment in the Intensive Care Unit”
by Camilo Pérez, Diana Diaz-Caicedo, David Fernando Almanza Hernández, Lorena Moreno-Araque, Andrés Felipe Yepes and Jorge Armando Carrizosa Gonzalez
J. Clin. Med. 2024, 13(18), 5344; https://doi.org/10.3390/jcm13185344
Full text available online: https://www.mdpi.com/2077-0383/13/18/5344

To further promote academic exchanges and knowledge dissemination, we sincerely invite new scholars to subscribe to our journals. Here, you will get the latest research news for the first time and have the opportunity to make your research results shine on a broader platform. Please click the following link to learn more about the journal: https://www.mdpi.com/journal/jcm.

6 January 2025
Meet Us at the ESCMID Global 2025, 11–15 April 2025, Vienna, Austria


MDPI will attend ESCMID Global 2025, which will take place in Vienna, Austria, from 11 April to 15 April 2025.

ESCMID Global is the largest international meeting of its kind, and it plays a pivotal role in bringing together the global scientific community to exchange knowledge, share insights, and collaborate on cutting-edge research. Last year, the conference attracted 18,599 registered participants and received more than 7,800 abstract submissions from more than 129 countries. This overwhelming response underscores the ongoing growth of the ESCMID Global community and its leadership role in the field of infections. The submissions covered a wide range of topics and allowed for the curation of an outstanding and diverse programme that showcased the latest research and innovations from leading experts in the field.

The following MDPI journals will be represented at the conference:

If you are planning on attending this conference, please do not hesitate to stop by our booth, K40, and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.escmid.org/congress-events/escmid-global/vienna-2025/.

31 December 2024
Journal of Clinical Medicine | Review of the Cooperation with the Italian Society of Thoracic Endoscopy (SIET)


Background and Overview of the Cooperation

Our cooperation with SIET (Italian Society of Thoracic Endoscopy) began in September 2023. Since then, we have been committed to promoting the establishment of topics in the fields related to our collaboration, initiating Special Issues, enriching the cooperation potential in this area, and advancing together. Our cooperation encompasses various modalities, such as providing discounted article processing charges (APCs) to all SIET members when submitting articles to the Journal of Clinical Medicine (JCM, ISSN: 2077-0383), participating in offline meetings, offering free media support, and sponsoring conferences. We will maintain a long-term cooperation and are currently exploring new collaboration models.

New Collaboration for the XXII SIET National Congress

Recently, SIET organized the XXII SIET National Congress. We actively promoted it through the conference section of our journal and social media accounts. Additionally, we sponsored the JCM Junior Competition to express our support. The XXII SIET National Congress was held in Florence from 17 to 19 October 2024 (https://www.sietfirenze2024.it/). The central aim of this congress was to skillfully combine the surgical techniques of Italian institutions with the latest emerging technologies, with the intention of inspiring and training young colleagues. The main participants included not only thoracic surgeons but also endoscopists, pulmonologists, oncologists, pathologists, radiologists, and anesthesiologists. Moreover, fifth- and sixth-year students of internal and surgical specialties also actively participated.

The JCM Junior Competition was a group competition, in which four teams competed on questions related to the theme of the congress. Each member of the winning team received 200 euros, with a total prize money of 800 euros. The conference chair, Prof. Mohsin Ibrahim, presented the awards. We encourage the researchers who attended the conference to submit their research results to our journal. We have 35 Sections (https://www.mdpi.com/journal/jcm/sections) available for them to choose from. The photos of the key members of the society and the winning team of the JCM Junior Competition are below.

Winning Team—JCM Junior Competition:

  • Spinelli Francesca, University of Milan;
  • Carleo Graziana, University of Bari—Aldo Moro;
  • Messina Maddalena, University of Siena—AOU Senese;
  • Giovanniello Delia, San Camillo Forlanini Hospital Rome.


Key members (from left to right): Prof. Mohsen Ibrahim, Ms. Francesca Cocquio and Dr. Federico Raveglia


Photos of the winners and jurors of the JCM Junior Competition

 Meeting with SIET Members and Future Prospects

Taking the opportunity to further our cooperation during this conference, we had the honor of visiting four SIET association members: Dr. Federico Raveglia, Dr. Paolo Scanagatta, Prof. Mohsen Ibrahim and Prof. Lorenzo Corbetta. The main purpose of this visit was to discuss current cooperation and look ahead to future collaborations. They were interested in using other services provided by JCM, especially the SciForum platform, which would make organizing conferences and webinars much easier for them.

Dr. Raveglia has accepted our review invitations on multiple occasions, laying a solid foundation for cooperation. We are extremely grateful for his efforts in ensuring the quality of journal manuscripts.

Dr. Scanagatta participated in the establishment of a Special Issue this year and served as a Guest Editor. He was highly satisfied with the editing process, which was a pleasant collaboration. We look forward to maintaining a continuous and fruitful partnership with him and publishing more high-quality manuscripts. Although Prof. Corbetta had not cooperated with us before and was unaware of the details of our partnership with SIET, he showed particular interest. He indicated that he would consider collaborating with us, and he is also a member of other associations. This presents new opportunities for potential partnerships and further development. This visit was an excellent opportunity for mutual understanding and further confirmation of new partnership models and content.

We express our sincere gratitude for our partnership with SIET so far and look forward to an even more prosperous future. We anticipate that the journal and the organization will continue to strengthen their cooperation in various aspects. We expect to explore more topics, encourage more scholars to contribute their research, and enhance the influence and academic value of both sides.

For more information about societies affiliated with JCM, please visit the following link: https://www.mdpi.com/journal/jcm/societies.

31 December 2024
Join Us at MDPI Academic Publishing Exchange, 9 January 2025, Chiang Mai, Thailand


MDPI and Chiang Mai University, Thailand are collaborating to hold an academic publishing exchange as part of the International Symposium for Agricultural Biomedical Research Network hosted by Chiang Mai University. This exchange stems from the mutual interest of MDPI and Chiang Mai University in promoting academic research and scholarly publication, which will encompass a variety of topics. The participants will gain valuable insights into MDPI's publication process, refine their skills in writing scientific papers in English, improve their understanding of data visualization in publications, and explore the applications of artificial intelligence in scientific publishing.

As a leading international open-access publisher, MDPI offers a high-quality platform and comprehensive services to scholars globally. This exchange presents a significant opportunity for researchers to interact with experts in the field of agricultural biomedical research, enabling experts and early-career scientists to adapt to the evolving OA academic publishing industry.

Date: 9 January 2025
Time: 1:00 p.m.–3:45 p.m.
Venue: Inthanin Room (1st Floor), Green Nimman CMU Residence at UNISERV, Chiang Mai University
Registration: https://www.surveymonkey.com/r/8JHM5XH

Speaker

Program

Time

Assoc. Prof. Dr. Teera Chewonarin, Head of Biochemistry Department, Chiang Mai University

Opening Speech

1:00 p.m.–1:10 p.m.

Dr. Juthathip Poofery

MDPI and Journals Introduction

1:10 p.m.–1:30 p.m.

Dr. Krit Inthajak

How to Write Scientific Papers in English

1:30 p.m.–2:00 p.m.

 

Q&A Session

2:00 p.m.–2:10 p.m.

 

Break

2:10 p.m.–2:25 p.m.

Ms. Hathaipat Kittirojana

How to Respond to Peer Reviewers

2:25 p.m.–2:55 p.m.

 

Q&A Session

2:55 p.m.–3:05 p.m.

Ms. Ploy Assavajamroon

Artificial Intelligence in Scientific Publishing

3:05 p.m.–3:35 p.m.

 

Q&A Session

3:35 p.m.–3:45 p.m.

Chair

Biography


Assoc. Prof. Dr. Teera Chewonarin,
Head of Biochemistry Department, Chiang Mai University, Chiang Mai, Thailand

Dr. Teera Chewonarin holds a bachelor's degree in biochemical technology from the Faculty of Science, Chiang Mai University (1993), a master's degree in biochemistry from the Faculty of Medicine, Chiang Mai University (1997), and a Ph.D. in Biochemistry from the same institution (2001).

Currently, Dr. Teera serves as an Associate Professor at the Department of Biochemistry, Faculty of Medicine, Chiang Mai University. Additionally, he has been the Head of biochemistry Department since 2019. His professional expertise lies in biochemical toxicology, tumor biology, and chemoprevention.

Speakers

Biography


Dr. Juthathip Poofery

Dr. Juthathip Poofery holds a Ph.D. in biochemistry from the Faculty of Medicine, Chiang Mai University, Thailand. She began working at MDPI in 2021 as an Assistant Editor for Medicina and advanced to the position of Section Managing Editor in 2022. Since 2023, Dr. Poofery has been serving as the Group Leader of the Medical Science Section, where she oversees editorial operations and contributes to the advancement of research in the field.


Dr. Krit Inthajak

Dr. Krit Inthajak obtained his Ph.D. in engineering and technology from Sirindhorn International Institute of Technology, Thammasat University, Thailand. He joined MDPI in March 2020 as an Assistant Editor for Molecules. He was appointed as a Section Managing Editor in 2021 and worked as a Group Leader from 2021 to 2024. He is now one of MDPI's Regional Journal Relations Specialists for the Asia–Pacific region.


Ms. Hathaipat Kittirojana

Ms. Hathaipat Kittirojana obtained her master’s degree in food science and biotechnology from Teesside University, England. She joined MDPI in December 2020 as an Assistant Editor for the Journal of Imaging. She was appointed as a Section Managing Editor in March 2023 and a Regional Journal Relations Specialist for the Asia–Pacific region in July 2024.


Ms. Ploy Assavajamroon

Ms. Ploy Assavajamroon obtained her master’s degree in chemistry from Thammasat University in 2020 and joined MDPI as an Assistant Editor for the journal Crystals in the same year. She became a Section Managing Editor in 2021 and a Group Leader in 2022. She is currently one of MDPI's Regional Journal Relations Specialists for the Asia–Pacific region.

24 December 2024
Interview with Dr. Jasper Iske—Winner of the JCM 2023 Young Investigator Award


Name: Dr. Jasper Iske
Affiliation: 1. Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charite (DHZC), Berlin, Germany
2. Charite—Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, Berlin Institute of Health, Berlin, Germany

We wish to congratulate Dr. Jasper Iske on winning the JCM 2023 Young Investigator Award. Dr. Jasper Iske performs research in the field of heart transplantation at the department of Cardiothoracic and Vascular Surgery, the German Heart Center of Charité Berlin, Germany. We hope that you enjoy the interview.

We wish Dr. Jasper Iske every success in his current work, and we look forward to his future contributions to the journal.

For more information about the awards presented by JCM, please visit the following link: https://www.mdpi.com/journal/jcm/awards.

24 December 2024
Journal of Clinical Medicine | 2024 Editorial Board Meeting of the Section “Nephrology and Urology”


The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has held Editorial Board meetings since 2023. The Editorial Board meeting on 9 December 2024 for the Section “Nephrology and Urology” was hosted by Section Editor-in-Chief, Prof. Dr. Magdi Yaqoob, and eight Editorial Board Members were in attendance. We are extremely grateful for the strong support from our Editorial Board Members, and we sincerely hope that more Editorial Board Members will be able to participate in future meetings. We would like to invite everyone to review the content of this meeting.

The meeting began with a presentation about the development of the journal, with a particular focus on the Section “Nephrology and Urology”. The following topics were discussed:

  • The journal’s history, open access policy, and author benefits;
  • Journal publication statistics and analysis of authors’ demographics (2018–2024);
  • Journal awards, marketing activities, and social media promotion;
  • Section EBM overview, decision-making statistics, and Section development statistics.

To promote the development of the “Nephrology and Urology” Section, the following topics were discussed at this Editorial Board meeting:

  • Members provided valuable suggestions on the type of manuscripts handled by the Section. The focus was on handling more original manuscripts of high quality. In addition, it was suggested that manuscripts in the style of debate/controversy be included to increase topicality and attract more attention;
  • Members suggested creating additional columns such as the Student Column and Journal Clubs Column, which could increase the visibility and awareness of the Section in the academic community. Members suggested expanding the geographical distribution of the author groups, welcoming outstanding scholars from all over the world to join us, and supplementing the number of members. We warmly invite distinguished scholars to join us, as their expertise and influence will greatly contribute to the development of the Section;
  • Promotion plays a vital role in the development of the Section. Members suggested organizing webinars and establishing partnerships with large associations that have many members. Such partnerships are expected to increase the exposure of the Section and promote wider scholarly communication.

Attendee list (in no particular order):

  • Prof. Dr. Magdi Yaqoob (Section Editor-in-Chief), Department of Renal Medicine and Transplantation, William Harvey Research Institute and Barts Health NHS Trust, London, UK;
  • Prof. Dr. Giacomo Garibotto, 1 Department of Internal Medicine, Division of Nephrology, Dialysis and Transplantation, University of Genoa, Italy; 2 IRCCS Ospedale Policlinico San Martino, Genoa, Italy;
  • Dr. Peter Schnuelle, Vth Department of Medicine, University Medical Center Mannheim, Mannheim, Germany;
  • Dr. Maurizio Bossola, 1 Servizio Emodialisi, Università Cattolica del Sacro Cuore, Rome, Italy; 2 Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy;
  • Prof. Dr. Hein Van Poppel, University Hospital KU Leuven, Leuven, Belgium;
  • Prof. Dr. Klemens Budde, Department of Nephrology and Intensive Medical Care, Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Germany;
  • Dr. John K. Maesaka, NYU Langone Hospital – Long Island, Mineola, NY, USA;
  • Dr. Andreas Skolarikos, Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens, Greece;
  • Dr. Laetitia Dou, INSERM, INRA, C2VN, Aix Marseille University, Marseille, France.

The latest official CiteScore (2023 Scopus data) for the Journal of Clinical Medicine is 5.7, ranking 80/636 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.0 (2023), ranking 59/329 (Q1) in the “Medicine, General, and Internal” category.

To access more journal statistics, please click here.

To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Nephrology_Urology.

JCM Editorial Office

20 December 2024
Editorial Board Members from the Journal of Clinical Medicine Featured in the 2024 Highly Cited Researchers List Published by Clarivate


On 19 November 2024, ClarivateTM released its 2024 Highly Cited ResearchersTM list, for which 6636 researchers from universities, research institutes, and commercial organizations around the world were selected. We are pleased to announce that ten Editorial Board Members of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) have been selected for the list, recognized for their high-quality scientific research and outstanding contributions to their fields of expertise. The Editorial Office of the Journal of Clinical Medicine would like to congratulate all the selected Editorial Board Members and look forward to continuing our close and productive collaboration.

The following is a list of the ten Editorial Board Members who were named as highly cited researchers in 2024:

Researcher

Category

Affiliation

Timsit, Jean-Francois

Cross-Field

Université Paris Cité, France

Young, Allan H.

Cross-Field

King's College London, United Kingdom

Graus, Francesc

Neuroscience and Behavior

University of Barcelona, Spain

Vita, Antonio

Psychiatry and Psychology

University of Brescia, Italy

Lu, Shun

Clinical Medicine

Shanghai Jiao Tong University, China

Cottin, Vincent

Clinical Medicine

Hospices Civils de Lyon, Claude Bernard University Lyon 1, France

Peyrin-Biroulet, Laurent

Clinical Medicine

Universite de Lorraine, France

Henry, Brandon Michael

Cross-Field

Cincinnati Children's Hospital Medical Centre, Cincinnati, USA

Rocca, Maria A.

Neuroscience and Behavior

Vita-Salute San Raffaele University, Italy

Landi, Francesco

Cross-Field

Catholic University of the Sacred Heart, Italy

In addition, 685 Editorial Board Members of MDPI journals were honored, and we wish to congratulate them on their achievement and contributions to advancing knowledge in their respective fields. To access more information on the 685 Editorial Board Members, please visit the following link: https://www.mdpi.com/about/announcements/9911.

For more information about the JCM Editorial Board, please visit the following link: https://www.mdpi.com/journal/jcm/editors.


Displaying Announcement 41-50 on page 5 of 41.
Back to TopTop